Case Study
Customer Case Studies
How leading sponsors, CROs, and site networks deploy Maxis AI to recover cycle time, cost, and quality.
Biotech
Phase 1 Trial: First Patient In <100 Days. Under $400K.
How a Boston oncology biotech ran a first-in-human Phase 1 with 45% faster startup, 2–3× enrollment conversion, and 50% faster database lock — at under $400K versus a $2–5M traditional CRO bid.
Featured
Featured Case Studies
Large Pharma
Unified Governance. $3–5M Recovered. Per Trial.
Database lock delays were deferring $3–5M per study. See how a large pharma closed the gap.
Mid Pharma
Mid-Pharma: 35% Faster Lock with 40% Lower DM Spend
Scaling biometrics throughput without growing headcount.
Large CRO
Large CRO: $40–60M Margin Recaptured in FSP Biometrics
Reversing margin erosion through agentic delivery.
All
All Case Studies
SMB CRO
SMB CRO: 2–3× Growth, $200–400K Saved
Winning enterprise bids without scaling only through hiring.
Site Network
Site Network: Screen Failure 74% → 38%
Enrollment met 5 months early across an 8-site rare disease network.
Small Pharma
Small Pharma: Submission Readiness on First Pivotal Trial
Punching above weight on the first registrational study.
Explore our AI Workforce Platform
See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.